Table 3.
Changes in the Standardized Assessment of Global Activities in the Elderly and International Physical Activity Questionnaire score
| Rivaroxaban plus aspirin | Aspirin alone | |
|---|---|---|
| Mean (SD) SAGE scores at baseline | n = 9072 | n = 9092 |
| 2.97 (4.32) | 3.00 (4.31) | |
| Mean (SD) SAGE scores at final visit | n = 8277 | n = 8343 |
| 2.83 (4.15) | 2.80 (4.20) | |
| Adjusted difference in change from baseline (95% CI) | 0.04 (−0.07, 0.15) | |
| IPAQ | ||
| Mean (SD) IPAQ Total Physical Activity Scores at baseline, MET minutes/week | n = 9073 | n = 9079 |
| 5399.8 (8324.9) | 5279.8 (8317.6) | |
| Mean (SD) IPAQ Total Physical Activity Scores at final visit, MET minutes/week | n = 3950 | n = 3942 |
| 4478.5 (6936.1) | 4408.9 (6872.9) | |
| Adjusted difference in change from baseline (95% CI) | 59.8 (−214.5, 334.2) | |
CI, confidence interval; IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent of task; SAGE, Standardized Assessment of Global Activities in the Elderly; SD, standard deviation.